Rabbit Recombinant Monoclonal BID antibody. Suitable for IHC-P, ICC/IF, IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 29 publications.
View Alternative Names
BH3-interacting domain death agonist, p22 BID, BID
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-Bid antibody [Y8] (AB32060)
Overlay histogram showing HeLa cells stained with ab32060 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab32060 1/100 dilution) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1μg/1x106 cells) used under the same conditions. Unlabelled sample (blue line). Acquisition of >5000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Bid antibody [Y8] (AB32060)
Immunohistochemical analysis of paraffin-embedded human prostate carcinoma using ab32060 at 1/100 dilution.
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Bid antibody [Y8] (AB32060)
Immunocytochemistry analysis of MCF7 (human breast adenocarcinoma epithelial cell) labeling Bid with purified ab32060 at 1/500 dilution (10 µg/ml). Cells were fixed with 100% methanol. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/1000 (2 µg/ml) was used as the secondary antibody. ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 µg/ml) was used as counterstain. Nuclei were stained blue with DAPI.
Negative control : PBS instead of the primary antibody.
- IP
Lab
Immunoprecipitation - Anti-Bid antibody [Y8] (AB32060)
Purified ab32060 at 1/50 dilution (2μg) immunoprecipitating Bid in Jurkat whole cell lysate.
Lane 1 (input) : Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate 10μg
Lane 2 (+) : ab32060 + Jurkat whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab32060 in Jurkat whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 22 kDa
All lanes:
Immunoprecipitation - Anti-Bid antibody [Y8] (ab32060)
Predicted band size: 22 kDa
false
- WB
Unknown
Western blot - Anti-Bid antibody [Y8] (AB32060)
All lanes:
Western blot - Anti-Bid antibody [Y8] (ab32060) at 1/1000 dilution
All lanes:
Jurkat cell lysate
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
- WB
AbReview24935****
Western blot - Anti-Bid antibody [Y8] (AB32060)
All lanes:
Western blot - Anti-Bid antibody [Y8] (ab32060) at 1/500 dilution
Lanes 1 - 2:
Whole cell lysate prepared from breast cancer clinical extract at 20 µg
Lane 3:
Whole cell lysate prepared from MCF7 cells at 20 µg
Secondary
All lanes:
Goat anti-rabbit IgG-HRP at 1/1000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
true
Exposure time: 25min
Image courtesy of an anonymous Abreview.
Related conjugates and formulations (2)
-
HRP Anti-Bid antibody [Y8]
-
Anti-Bid antibody [Y8] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Bid induces mitochondria-mediated apoptosis that significantly affects cellular homeostasis. Bid is not considered to be part of a permanent protein complex; instead it acts as a mobile activator bridging interactions between different proteins within the apoptotic pathway. Upon activation tBID interacts with other Bcl-2 family members like Bax and Bak which leads to mitochondrial membrane permeabilization and subsequent release of cytochrome c.
Pathways
Bid significantly influences apoptotic signaling under different cellular stress conditions. It plays important functions in both intrinsic and extrinsic pathways of apoptosis. Within the intrinsic pathway Bid links the external death receptor signals to the mitochondria-mediated apoptotic pathway. In addition to interacting with Bax and Bak Bid indirectly connects to the apoptosome complex facilitating caspase activation which ultimately results in cellular apoptosis.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (29)
Recent publications for all applications. Explore the full list and refine your search
World journal of oncology 15:472-481 PubMed38751696
2024
Applications
Unspecified application
Species
Unspecified reactive species
BMC biology 20:123 PubMed35637473
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in molecular biosciences 8:790804 PubMed34988121
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular and molecular medicine 25:8312-8328 PubMed34363438
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 20:1161-1172 PubMed33850004
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 13:11150-11169 PubMed33819182
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 21:305 PubMed33732381
2021
Applications
Unspecified application
Species
Unspecified reactive species
Aging 12:6240-6259 PubMed32276266
2020
Applications
Unspecified application
Species
Unspecified reactive species
eLife 8: PubMed31294695
2019
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 234:20879-20887 PubMed31001861
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com